Measles Returns: 4,410 US Cases and the 95% Rule (2026)

Measles is returning to wealthy countries because vaccination coverage has slipped below the roughly 95% two-dose level the virus demands, and because the systems that used to catch children who miss doses have weakened at the same time as public trust has polarised ◈ Strong Evidence [4] [5] [6]. That is the core finding of this report. Measles is not a random event in these countries. It is a diagnostic. Because it is the most transmissible human virus known, it is the first disease to exploit a gap in immunity, and it does so years before slower pathogens such as diphtheria or polio would show the same weakness ✓ Established [7] [8]. When measles comes back, it is reporting on the state of primary care, school-entry checks, public-health budgets and institutional trust. In 2025 and 2026 that report has been bad across North America and much of Europe at once.

The global baseline frames the scale. The World Health Organization estimated about 11 million measles cases and 95,000 deaths worldwide in 2024 — deaths down 88% since 2000, but cases 8% higher than in 2019, the last year before the pandemic disrupted routine immunisation ✓ Established [8] [9]. Fifty-nine countries reported large or disruptive outbreaks in 2024 [8]. In 2023 the total had been 10.3 million cases and about 107,500 deaths, with more than 22 million children missing their first dose [10]. The July 2026 WHO/UNICEF coverage estimates showed first-dose coverage stuck at 84% and second-dose coverage at 77% in 2025 — essentially flat against the year before ✓ Established [11] [12]. The world is not losing ground in aggregate. It is simply not gaining it, and in a disease this contagious, standing still at 84% guarantees continuing outbreaks.

The novelty of 2024 to 2026 is where the outbreaks landed. The WHO European Region recorded 127,350 cases in 2024, double the 2023 figure and the highest count since 1997 ✓ Established [4]. Romania alone reported 30,692 cases and Kazakhstan 28,147 [4]. Inside the EU and European Economic Area, the European Centre for Disease Prevention and Control counted 35,212 cases — ten times the 3,973 of 2023 — and found that only four EU/EEA countries reached 95% coverage with the second dose [13]. Cases fell by about 75% in 2025, to 33,998, yet the number of countries in the region with endemic or re-established transmission rose from 12 to 19 [14]. Fewer cases, wider footprint: the virus had found more places to live.

North America moved faster and further. In 2025 the United States recorded more than 2,250 confirmed cases and three deaths, the highest annual count since 1992 ✓ Established [15]. The West Texas outbreak alone produced 762 cases, 99 hospitalisations and the deaths of two unvaccinated school-age children [16]. Then 2026 overtook it. By 15 October the Centers for Disease Control and Prevention (CDC) had counted 4,410 cases and 451 hospitalisations, with a Pennsylvania outbreak of 1,260 cases that led Pennsylvania and New York to declare disaster emergencies ✓ Established [1]. Jennifer Nuzzo of Brown University’s Pandemic Center put it plainly: “We are currently in the worst bout of measles that the United States has seen in more than 30 years” [15].

Canada crossed the line the United States is approaching. On 10 November 2025 the Pan American Health Organization (PAHO) confirmed that a single measles lineage had circulated in Canada for more than 12 months, ending an elimination status the country had held since 1998 ✓ Established [2]. The outbreak, which began in New Brunswick in October 2024, had produced 5,162 confirmed cases in 2025 by the time of the announcement and the deaths of two preterm infants [17]. When it was declared over on 19 October 2026, 6,417 cases had been linked to it, led by Ontario with 2,390 and Alberta with 2,299 [18]. PAHO’s director, Jarbas Barbosa, called the loss a setback that is “also reversible” [17]. The United States’ own status is under review by PAHO at its November 2026 meeting, after a review set for April was postponed [19] [20].

Europe’s reversals are less dramatic in numbers but just as diagnostic. The announcement in late January 2026 that the United Kingdom had lost elimination status — for the second time, after losing it in 2018 and regaining it in 2021 — came alongside the same verdict for Spain and Austria ✓ Established [3] [5]. England recorded 2,911 laboratory-confirmed cases in 2024, the most since 2012 [3]. Across the UK, first-dose MMR coverage fell from 95.3% in 2016 to 92.3% in 2024, and second-dose coverage from 88.2% to 84.4% [5]. These are not the statistics of a country that has stopped believing in vaccines. They are the statistics of a system that no longer reaches every child on time — a distinction this report returns to repeatedly, because the policy response depends on getting it right.

The arithmetic of measles is simple, and it is unforgiving. The basic reproduction number, R0, is the average number of people one infected person infects in a population with no immunity. Systematic reviews put measles at 12 to 18, far above influenza at around 1 to 2 or the original strain of SARS-CoV-2 at around 2 to 3 ✓ Established [7]. The share of a population that must be immune to stop sustained spread is 1 minus 1 divided by R0. At an R0 of 12 that gives 91.7%; at 18 it gives 94.4% [7]. Vaccination is very effective but not perfect: one MMR dose is 93% effective against measles and two doses are 97% effective, according to the CDC [22]. Divide the immunity threshold by vaccine effectiveness and the required coverage with two doses lands at roughly 95% — the figure WHO uses as its target ✓ Established [22] [13].

That leaves a margin of two or three percentage points between a protected population and an exposed one. The United States sits inside that margin on the wrong side. National kindergarten MMR coverage was 92.5% in the 2024-25 school year and 92.4% in 2025-26, the fifth and sixth consecutive years below 95% ✓ Established [23] [24]. Exemptions rose from 3.3% to 3.6% in 2024-25 and to about 4.0% in 2025-26, with 24 states above 5% [23] [24]. Roughly 286,000 kindergartners entered school in 2024-25 without documented MMR vaccination [23]. In England, two-dose coverage at age five was 83.7% in 2024-25, more than 11 points below target ✓ Established [25]. Across 2024 only four EU/EEA countries met the 95% mark for the second dose [13].

National averages also understate the danger, because susceptibility is not spread evenly. Unvaccinated children cluster — in particular schools, congregations, neighbourhoods and language communities — and measles moves through clusters, not averages ◈ Strong Evidence [26] [27]. Gaines County, Texas, where the 2025 West Texas outbreak began, had a kindergarten exemption rate of 18% in 2023-24, nearly one child in five [26]. Canada’s largest chains of transmission ran through Low German-speaking Mennonite communities in southwestern Ontario where coverage has historically been low [27]. A state at 92% can contain dozens of schools at 70%. The national figure tells you how likely an outbreak is to start somewhere. The cluster figures tell you how big it will become once it does.

• R0 of 12 to 18: each case infects 12 to 18 susceptible people, against about 1 to 2 for seasonal influenza [7] ✓ Established.
• Immunity threshold of 92% to 94%: derived as 1 minus 1 divided by R0 [7] ✓ Established.
• Vaccine effectiveness of 93% and 97%: after one and two MMR doses respectively [22] ✓ Established.
• Coverage target of about 95%: the two-dose level that converts vaccination into population immunity [22] [13] ✓ Established.
• Observed gap: US kindergartners at 92.4%, England at 83.7% for two doses by age five, only four EU/EEA countries at target [24] [25] [13] ✓ Established.

The arithmetic explains why measles is the canary rather than one of the other vaccine-preventable diseases. Polio, diphtheria and pertussis have lower reproduction numbers, so populations can drift further below target before they show sustained outbreaks ◈ Strong Evidence [7]. Measles needs only a few points of slippage. That is precisely what makes it useful as a diagnostic: it detects erosion while other diseases are still silent. The return of pertussis in 2024 — 14,905 cases in England against 856 the year before, and 35,435 in the United States against 7,063 — shows that the same warning is spreading to other pathogens, even though pertussis is shaped by waning immunity and natural cycles as well as coverage [28] [29].

Measles also does more damage than its acute symptoms suggest. A 2015 study in Science by Michael Mina and colleagues found that measles suppresses resistance to other infections for two to three years, and that deaths from non-measles infections in several countries tracked measles incidence with that lag before and after vaccine introduction ✓ Established [30]. In 2019, a team using antibody profiling on 77 unvaccinated Dutch children found that measles erased between 11% and 73% of each child’s pre-existing antibody repertoire [31]. Mina described the result as “the best evidence yet that immune amnesia exists and impacts our bona fide long-term immune memory” [31]. An outbreak therefore leaves behind a cohort of children who are, for a period, more vulnerable to everything else.

The arithmetic finally explains why small changes in policy or trust can have large consequences. A one-point fall in national coverage sounds trivial in a political debate. In a disease with an R0 of 15, it can be the difference between sporadic imported cases that fizzle out and continuous chains of transmission that persist for a year and end elimination status ◈ Strong Evidence [7] [21]. The United States recorded 1,282 cases in 2019 and narrowly kept its elimination status that year [32] [21]. Six years later, the country is again waiting on a PAHO verdict, with a larger case count and a narrower margin [20].

If measles is a diagnostic, the useful question is what exactly it is diagnosing. The evidence points to three overlapping failures rather than one. The first is access: the practical difficulty of getting a child vaccinated on time, which falls hardest on poorer and more mobile families ◈ Strong Evidence [34] [35]. The second is follow-up: the erosion of the systems — health visitors, school-entry checks, reminder and recall — that used to find children who missed a dose ◈ Strong Evidence [36] [37]. The third is trust: the decline and polarisation of confidence in vaccines and in the institutions that recommend them ◈ Strong Evidence [38] [6]. Each failure produces outbreaks, but each requires a different remedy, and much of the public debate collapses all three into a single story about anti-vaccine sentiment.

The pandemic exposed all three at once. WHO and UNICEF estimated that 67 million children worldwide missed some or all routine vaccinations between 2019 and 2021, 48 million of them receiving none, and that coverage fell in 112 countries ✓ Established [33]. UNICEF described the result as more than a decade of hard-earned gains eroded [33]. Its 2023 State of the World’s Children survey found that the perceived importance of childhood vaccines fell in 52 of 55 countries after the pandemic began, with some of the steepest falls in Japan and South Korea ✓ Established [39]. The 2025 coverage data show a separate leak in the pipeline: 7.3 million infants received their first diphtheria-tetanus-pertussis dose and then dropped out before their first measles dose — children who reached the system and were then lost by it [11].

England offers the clearest data on the access and follow-up failures. Two-dose MMR coverage at age five fell for five consecutive years to 83.9% in 2023-24, the lowest since 2009-10, and slipped again to 83.7% in 2024-25 ✓ Established [40] [25]. London stood at 73.3% in 2023-24 against 89.7% in the North East [40]. The authors of the BMJ deprivation study concluded that “these findings strongly support the urgent need for effective strengthening of vaccination systems, proportionate to levels of need” ◈ Strong Evidence [34]. A qualitative study in Newham, East London, found that the barriers parents described mixed difficulty booking a GP appointment with post-pandemic mistrust — access and attitude overlapping in the same households [35].

Behind those numbers is a workforce story. Health visitors are the nurses who see families with young children at home and are often the first to notice a missed vaccination. After commissioning of the service moved from the NHS to local councils in 2015, and the public-health grant to councils was cut, health visitor numbers in England fell by about 21% between 2016 and 2021, according to a UCL study ◈ Strong Evidence [36]. The Institute of Health Visiting reports caseloads above safe levels in most local authorities [36] [41]. When the people whose job is to find missed children disappear, coverage declines first in the places with the most missed children — which is precisely the gradient the BMJ study found [34].

The trust failure is real but has a specific shape. Confidence in the MMR vaccine itself remains high in most rich countries. In the United States, Pew Research Center found in 2025 that 84% of adults say the benefits of MMR outweigh its risks, including 78% of Republicans ✓ Established [38]. A KFF and Washington Post survey of parents in 2025 found 90% saying MMR is important [42]. What has collapsed is support for the institutional arrangements around vaccination. Pew found support for requiring MMR to attend public school fell from 82% in 2019 to 69% in 2025, and from 79% to 52% among Republicans ✓ Established [38]. Gallup found that the share of Americans calling childhood vaccination extremely important fell from 64% in 2001 to 40% in 2024 [43].

That polarisation is now visible in the medical record, not just in polls. A study published in August 2026 in Lancet Regional Health Americas linked the health records of 46,924 children to their parents’ voter files and found that the partisan gap in vaccine refusal reached 9.2 percentage points for children born in 2021, widening by about 0.25 points a year since around 2000 ◈ Strong Evidence [6]. The gap was 3.3 points larger in states that allow non-medical exemptions [6]. The authors concluded that “political identity has become an increasingly important factor in childhood health decision-making” [6]. Europe shows an older version of the same pattern: the Wellcome Global Monitor found in 2018 that 33% of people in France disagreed that vaccines are safe, the highest share in the world [44].

The diagnostic value of measles lies in combining these signals. Where outbreaks track deprivation and coverage gaps follow the map of under-resourced services, the problem is mainly access and follow-up, as in much of England and Romania ◈ Strong Evidence [34] [4]. Where outbreaks run through communities with high exemption rates and organised objection, as in Gaines County or parts of southwestern Ontario, trust and identity dominate [26] [27]. Where both are present — where weakened services meet polarised trust — outbreaks become the long, multi-jurisdiction chains that end elimination status. That is the pattern North America has shown since 2024 [2] [1].

The human cost of the return of measles is concentrated, and it falls mostly on children. On 26 February 2025 an unvaccinated school-age child died in Lubbock, Texas — the first measles death in the United States since 2015 ✓ Established [45]. A second child in the same outbreak died weeks later, and an adult died in New Mexico [16] [15]. By the time the West Texas outbreak was declared over on 18 August 2025, it had produced 762 cases and 99 hospitalisations, with more than 94% of cases unvaccinated or of unknown status [16]. In July 2025 a child died at Alder Hey Children’s Hospital in Liverpool, which had treated 17 severe cases in the preceding weeks [46]. In Canada, two preterm infants exposed to measles before birth died [17].

The 2026 death count in the United States is itself contested, which is part of the story. The CDC had confirmed two measles deaths by mid-October, while Pennsylvania state and coroner reports put the number at five or six ⚖ Contested [1] [47]. The difference reflects reporting lags and a federal decision to rely on national mortality statistics rather than state case reports [1]. Measles deaths are rarely recorded instantly: many come from pneumonia or encephalitis days or weeks after the rash, and some from a rare brain disease called subacute sclerosing panencephalitis years later [48]. A count that waits for every death certificate will lag a fast-moving outbreak, and in a polarised environment the lag itself becomes a source of distrust.

Hospitalisation is the more reliable measure of severity in rich countries. The CDC estimates that about one in five unvaccinated people in the United States who get measles is hospitalised ✓ Established [48]. In 2026 the observed rate was 10% overall and 15% among children under five [47]. Of the 4,410 cases counted by 15 October, 42% were aged 5 to 19 and 41% were adults — a sign that the immunity gap now extends beyond infants into older children and young adults who missed doses years ago [1]. Across the WHO European Region in 2024, more than 40% of cases were children under five and more than half of reported cases were hospitalised [4].

Measles also leaves damage that never appears in its own statistics. The immune-amnesia research suggests that a measles epidemic is followed by two to three years of excess deaths and illness from other infections, because the virus wipes out a substantial share of the immune memory children have built up ✓ Established [30] [31]. In the 2019 study, children lost on average about 40% of their antibody repertoire after severe measles and 33% after mild measles [31]. None of that shows up in a measles death count. It shows up, diffusely, in pneumonia admissions and antibiotic prescriptions in the years after an outbreak — costs that are real but almost never attributed to the measles that caused them.

Outbreaks are also expensive to stop. A CDC-led analysis of 11 US outbreaks between 2001 and 2018 found a median public-health response cost of $32,805 per case and $152,308 per outbreak, with costs per case ranging from $7,396 to $76,154 ✓ Established [49]. The 2019 outbreak in Clark County, Washington — 71 cases — cost an estimated $3.4 million in total, or $47,479 per case, including about $2.3 million in public-health response and $1.0 million in lost productivity [50]. Each case requires tracing and contacting dozens of exposed people, checking their immunity and sometimes quarantining them. At those rates, the 4,410 US cases of 2026 imply public-health response costs well above $100 million before any medical bills, by simple multiplication of the median cost per case [49] [1].

Measles is not returning alone. England recorded 14,905 pertussis cases in 2024 and ten infant deaths; the United States recorded 35,435 cases ◈ Strong Evidence [28] [29]. Japan’s pertussis count passed 31,000 by mid-2025, eight times the 2024 total, partly driven by macrolide-resistant strains [51]. Poliovirus was detected in London sewage in 2022, and the same year a young man in Rockland County, New York, was paralysed by vaccine-derived poliovirus that wastewater sampling suggested had circulated silently for about a year [52]. Europe saw its largest diphtheria outbreak in roughly 70 years, with 359 cases in 2022 [53]. These diseases have different epidemiology, but they share the same precondition: a population with growing pockets of non-immunity.

The cost structure of the problem is perverse. Vaccinating a child against measles is cheap and is done once or twice. Responding to an outbreak is expensive and is done after children are already in hospital ◈ Strong Evidence [49] [50]. The budgets that pay for prevention — primary care, health visiting, public-health grants — are the ones that have been cut in England and, since 2025, in the United States [36] [54]. The budgets that pay for outbreak response are emergency budgets, drawn on after the fact. A system that saves money on the first will spend it, with interest, on the second.

The United States is the largest current test of whether a rich country can keep measles elimination under political strain. It declared elimination in 2000, after a 1989-1991 resurgence of more than 55,000 cases and 123 deaths among mostly unvaccinated preschool children in poor urban areas — a failure of access, not of belief ✓ Established [32] [56]. The current resurgence has a different profile. Kindergarten exemptions have reached about 4% nationally and exceed 5% in 24 states, and the 2026 outbreaks have spread through Utah, Pennsylvania, New York and other states in chains that PAHO is now reviewing [24] [1] [20]. Noel Brewer, who chairs the US committee responsible for documenting measles elimination, told STAT in August 2026 that the country’s failure to prevent child deaths from a preventable disease was its own [20].

Canada is the country that has already crossed the threshold. Its elimination status, held since 1998, ended on 10 November 2025 ✓ Established [2]. Canada accounted for about half of all measles cases in the Americas in 2025, with transmission concentrated in Low German-speaking Mennonite communities in southwestern Ontario and in Alberta, which was hardest hit per capita [27]. The outbreak was declared over on 19 October 2026 after 6,417 linked cases [18]. Canada demonstrates that a high-income country with universal health care and no organised federal anti-vaccine policy can still lose elimination when coverage gaps concentrate in tight-knit communities with low contact with mainstream services.

England combines a falling national average with a sharp social gradient. Two-dose MMR coverage at age five was 83.7% in 2024-25, the lowest since 2009-10, with London at 73.3% in 2023-24 ✓ Established [25] [40]. The deprivation gap more than doubled between 2019 and 2023 [34]. The UK lost elimination status for the second time in January 2026 [3] [5]. Vanessa Saliba, a consultant epidemiologist at the UK Health Security Agency, warned that infections can return quickly when childhood vaccine uptake falls [5]. England’s case is closest to a pure system diagnostic: confidence in MMR has not collapsed, but the services that deliver it have thinned.

Romania is the extreme European case. It reported 30,692 measles cases in 2024 according to WHO Europe, and 27,568 cases and 18 deaths according to the ECDC’s EU-level surveillance — more than three-quarters of all EU/EEA cases that year ✓ Established [4] [13]. First-dose coverage in Romania had fallen below 80% in 2023, alongside Bosnia and Herzegovina, Montenegro and North Macedonia [4]. Romania’s outbreaks have run for years, which makes it a warning about where sustained low coverage leads once it becomes the norm rather than the exception [13] [4].

Germany and Japan represent different versions of partial success. Germany introduced a measles vaccination requirement for daycare and school in March 2020 under the Measles Protection Act, with fines of up to 2,500 euros ✓ Established [57]. Two-dose coverage at 24 months reportedly rose from 70% to 77% and at school entry from 89% to 92% between 2019 and 2023, though only two federal states reach 95% [58]. Germany recorded 637 cases in 2024 [13]. Japan, verified as having eliminated measles in 2015, recorded 265 cases in 2025 and 498 confirmed cases by week 20 of 2026, more than any full year since 2020 ✓ Established [59] [55]. First-dose coverage fell from 95.4% in fiscal 2022 to 92.7% in fiscal 2024 [55].

Japan’s history adds a second lesson: policy shocks echo for decades. The country withdrew its MMR vaccine in 1993 after aseptic meningitis linked to the Urabe mumps strain occurred at about one in 900 doses, and mumps vaccination has remained voluntary since ✓ Established [60]. Separately, a rubella outbreak in 2018-19 exceeded 5,000 cases, mostly among men in their forties and fifties who had missed vaccination as children, and five babies were born with congenital rubella syndrome [61]. Japan responded with free antibody tests and vaccination for men born between 1962 and 1979 [61]. The authors of a 2026 study of Japan’s measles resurgence drew the general conclusion that elimination is reversible everywhere [55].

Read together, the six countries show that the measles signal is general but its cause is local. In North America, the dominant drivers are exemption law, community clustering and political polarisation ◈ Strong Evidence [6] [24] [27]. In England, the driver is a thinning, unequally distributed delivery system [34] [36]. In Romania, it is long-term access failure [4]. In Japan, it is the arithmetic of importation meeting coverage that slipped just below 95% [55]. Germany shows that a requirement can raise coverage without, on its own, reaching the target [58]. Every one of these countries could tell itself a reassuring story about its national average. Measles has been more honest.

The policy toolkit for raising coverage is well tested. School and daycare entry requirements are the most powerful lever, and the evidence on them is largely positive ◈ Strong Evidence [63] [65] [66]. Italy’s 2017 law raised the number of mandatory childhood vaccines from four to ten and barred unvaccinated children from nurseries. First-dose measles coverage, which had fallen from 90.4% in 2013 to 85.3% in 2015, rose to 94.4% by 2019 [63]. France extended its mandatory list from three to eleven vaccines for children born from 2018; in Auvergne-Rhône-Alpes, first-dose MMR coverage at 12 months rose from 85.5% to 87.7% [64]. Germany’s 2020 requirement raised school-entry two-dose coverage from 89% to 92% [58].

The North American evidence is similar. California’s SB277, in force from 2016, ended personal-belief exemptions for school entry; the share of kindergartners not up to date fell to 4.87% in 2017, though medical exemptions roughly tripled as some families found an alternative route ◈ Strong Evidence [65]. New York repealed religious exemptions in June 2019 during its outbreaks, and a later cohort study found coverage rose in schools outside New York City with no offsetting rise in medical exemptions [66]. Australia’s No Jab No Pay policy, which tied family benefits to vaccination from 2016, caught up nearly one in five young people not fully vaccinated against measles in its first two years [69], although a University of Western Australia study argued coverage had already been rising and the policy’s effect was overstated ⚖ Contested [70].

Since 2025, United States federal policy has run in the opposite direction. On 9 June 2025 the Secretary of Health and Human Services, Robert F. Kennedy Jr., removed all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP), the body that sets the national vaccine schedule, and named eight replacements ✓ Established [67]. In September 2025 the reconstituted committee voted against the combined measles-mumps-rubella-varicella vaccine for children under four [71]. On 5 January 2026 HHS reduced the number of diseases on the routine childhood schedule from 17 to 11 without the usual ACIP process [68]. On 16 March 2026 a federal judge issued a preliminary injunction suspending the new ACIP appointments, the votes of the reconstituted panel and the January schedule [72].

The institutional damage extended beyond the schedule. The White House fired the CDC director, Susan Monarez, on 28 August 2025, less than a month after her confirmation, and several senior officials resigned ✓ Established [73]. In March 2025 HHS cancelled $11.4 billion in pandemic-era grants to state and local health departments, money that in part funded routine vaccination and surveillance [54]. In June 2025 the United States withdrew a $1.6 billion pledge to Gavi, the international vaccine alliance [74]. In September 2025 Florida announced a plan to end all vaccine mandates, including for school entry, though by April 2026 the state legislature had removed none and added only a conscience exemption [75] [76].

The federal response to the Texas outbreak illustrated the shift. During the outbreak, Kennedy promoted vitamin A and cod liver oil as treatments rather than leading with vaccination ◈ Strong Evidence [77]. WHO does recommend vitamin A for children with measles, particularly where deficiency is common, and it reduces severe outcomes in those settings [9]. But Covenant Children’s Hospital in Lubbock treated children with measles who had elevated vitamin A levels and abnormal liver function, and one local paediatrician said some parents were giving high doses instead of vaccinating [78]. Peter Hotez of Baylor College of Medicine said vitamin A becomes “a distraction” from vaccinating children [77]. The issue was not the vitamin. It was the substitution of treatment for prevention in official messaging.

The international funding picture compounds the domestic one. In April 2025 WHO and UNICEF warned that cuts to global health funding put measles gains at risk, and UNICEF’s executive director, Catherine Russell, said the funding crisis was “severely limiting our ability to vaccinate over 15 million vulnerable children in fragile and conflict-affected countries against measles” ✓ Established [79]. Rich countries import measles from wherever it circulates. Japan’s 2026 resurgence was largely importation-driven, and Canada’s chief public health officer warned when its outbreak ended that the country should expect further travel-related cases [55] [18]. Underfunding vaccination abroad raises the number of sparks that land on domestic coverage gaps.

The first contested question is whether vaccination requirements raise coverage or harden opposition ⚖ Contested [80] [81]. The coverage data from Italy, France, Germany, California and New York show increases after requirements were tightened [63] [64] [58] [65] [66]. An experimental study of US populations found that requiring vaccination strengthened intentions to vaccinate across levels of psychological reactance, the trait that makes people resist being told what to do [80]. On the other side, qualitative research by the political scientist Katie Attwell found that heavy-handed policies can entrench opposition in a committed minority, and California’s experience showed that families determined to avoid vaccination can shift to medical exemptions [81] [65]. The balance of evidence favours requirements for raising average coverage; the open question is what they do to the most resistant clusters, where outbreaks begin.

The second question is whether falling coverage is mainly a problem of hesitancy or of access ⚖ Contested [34] [38]. Public debate in the United States frames it as hesitancy, and the rise in non-medical exemptions supports that framing for a growing minority [24] [6]. But in England the steepest declines are among the most deprived families, while stated confidence in MMR remains high, which points to access and follow-up [34] [37]. The US resurgence of 1989-1991, which killed 123 people, was driven by poor access in urban areas rather than by belief [32]. The Newham study suggests the two often coexist in the same family: a parent who is mildly uncertain and who cannot get an appointment easily is the parent whose child goes unvaccinated [35]. Treating every gap as hesitancy wastes money on persuasion where convenience would work.

The third question is the mortality rate itself. The CDC’s figure of 1 to 3 deaths per 1,000 infected children is the standard public-health estimate ⚖ Contested [48]. Sceptics argue that it overstates the risk in high-income countries with modern intensive care, and point to observed rates well below that in Canada’s outbreak [18] [82]. Public-health researchers respond that death is only the most visible outcome: hospitalisation of one in five unvaccinated cases, encephalitis, immune amnesia and the rare but fatal brain disease that can appear years later are the larger burden [48] [30]. The 2026 dispute over US death counts shows how this argument becomes political: a lower official count is read by one side as reassurance and by the other as concealment [1] [47].

The fourth question is how far declining institutional trust drives the coverage decline. The polling is clear that support for school requirements has fallen sharply among Republicans in the United States, and the 2026 health-records study shows that partisan identity now predicts vaccine refusal for young children ◈ Strong Evidence [38] [6]. Gallup data show a long decline in the share of Americans who see childhood vaccination as extremely important [43]. But trust in the MMR vaccine itself remains high across both parties, and coverage losses in England and Japan occurred without a comparable partisan realignment ⚖ Contested [38] [55] [25]. Distrust is a powerful amplifier in North America. It is not a universal explanation.

The two cases are not mutually exclusive, and the outbreaks of 2025 and 2026 suggest they reinforce each other ◈ Strong Evidence [34] [6]. When services are thin, the families most likely to be missed are poorer and less connected. When trust is polarised, the families most likely to opt out are concentrated in particular communities. Measles exploits both kinds of gap, and it spreads fastest where they overlap — in a congregation with high exemptions served by an overstretched clinic, or a deprived district with an unfilled health visitor post and a parent whose doubts no one has time to address [35] [26].

The misinformation ecosystem sits behind the trust argument, and its scale is easier to measure than its effect. In 2021 the Center for Countering Digital Hate attributed 65% of 812,000 anti-vaccine posts on Facebook and Twitter over six weeks to twelve accounts, one of them Robert F. Kennedy Jr. ◈ Strong Evidence [83]. Meta disputed the methodology [83]. The paper that launched modern MMR doubts, Andrew Wakefield’s 1998 article in The Lancet, was fully retracted in 2010 [62]. A quarter of a century of debunking has not prevented the core claim from circulating, which suggests that correcting information is necessary but insufficient. People do not trust a fact more than they trust the institution delivering it [84] [38].

The evidence assembled in this report supports a clear conclusion. Measles has returned to the wealthiest countries because coverage has fallen a few points below the roughly 95% the virus requires, and because those points are concentrated in clusters where outbreaks start and grow ◈ Strong Evidence [22] [7] [26]. The causes of the fall differ by country — access and workforce in England, exemptions and polarisation in the United States, community clustering in Canada, long-term access failure in Romania, importation in Japan — but the outcome is the same: elimination, once treated as permanent, has proved reversible [55] [2] [3].

That makes measles a uniquely valuable diagnostic. Its reproduction number of 12 to 18 means it detects immunity gaps that slower diseases would not reveal for years ✓ Established [7]. Pertussis, polio and diphtheria have already followed it back into wealthy countries in 2022 to 2025 [28] [52] [53]. A country that tracks measles outbreaks closely, and asks where and why they occur, gets early warning about the integrity of its entire childhood immunisation programme — and, more broadly, about whether its primary care and public-health services still reach the families who need them most.

The policy lessons follow from the diagnosis. Where the problem is access, the remedy is convenience: evening and weekend clinics, pharmacy vaccination, school-based catch-up and active recall of children who miss doses ◈ Strong Evidence [34] [35]. Where the problem is follow-up, it is workforce and data: health visitors, school nurses and registries that flag missed doses in real time [36] [37]. Where the problem is trust, requirements raise average coverage, but the clusters that seed outbreaks also need credible local messengers and consistent national institutions [80] [81] [63]. No single lever reaches 95% on its own, as Germany’s partial success shows [58].

• For public-health agencies: publish coverage at school and neighbourhood level, not only national averages, so clusters are visible before outbreaks begin [23] [26] ◈ Strong Evidence.
• For health systems: fund the follow-up workforce — health visitors and school nurses — that finds missed children, because coverage falls first where it thins [36] [34] ◈ Strong Evidence.
• For legislators: school-entry requirements with narrow exemptions raise coverage, as Italy, France, Germany, California and New York show [63] [64] [58] [65] [66] ✓ Established.
• For international donors: funding measles vaccination abroad reduces the importations that seed outbreaks at home [79] [55] ◈ Strong Evidence.
• For everyone reading outbreak data: treat each outbreak as a report on the system, asking which failure dominates in that place — access, follow-up or trust [34] [6] ◈ Strong Evidence.

The United States is the case to watch in the coming months. PAHO is due to review its elimination status in November 2026, after transmission chains that began in January 2025 ✓ Established [19] [20]. If the United States loses its status, it will join Canada and the United Kingdom in a group of wealthy countries that achieved one of public health’s clearest victories and then let it slip. The cause will not be the virus, which has not changed. It will be the arithmetic of a few percentage points, the institutions that used to close them, and the trust that made those institutions work.

The canary metaphor is apt in one more way. Miners did not watch canaries out of concern for canaries; they watched them because the birds detected an invisible danger before it reached the miners themselves ◈ Strong Evidence [8] [7]. Measles plays that role for health systems. It is detecting erosion that will, if left alone, show up in pertussis, polio and diphtheria, and in a more general loss of the capacity to reach and persuade the public [28] [52] [53]. The 2024 to 2026 readings are clear. Whether rich countries treat them as a warning or as noise will decide what the next set of readings shows.